Liang‐Chuan S. Wang

2.6k citations

21 papers · 2.2k indexed · 3 hit papers · h-index 15

Co-authors: Steven Μ. Albelda Veena Kapoor Carl H. June Edmund K. Moon Albert LoJing SunEllen Puré Amy C. Durham
Topics: Immunotherapy and Immune Responses (6 papers)Immune Cell Function and Interaction (5 papers)CAR-T cell therapy research (4 papers)
Cited by: Oncology Immunology Genetics
Journals: Journal of Biological Chemistry Cancer Research Clinical Cancer Research
Partner nations: United States New Zealand Germany

In The Last Decade

Liang‐Chuan S. Wang

21 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity

2013 515 citations Liang‐Chuan S. Wang, Albert Lo et al. Cancer Immunology Research profile →
Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor

2011 447 citations Edmund K. Moon, Carmine Carpenito et al. Clinical Cancer Research profile →
Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells

2015 407 citations Albert Lo, Liang‐Chuan S. Wang et al. Cancer Research profile →

Peers

Countries citing papers authored by Liang‐Chuan S. Wang

Since Specialization

Citations

This map shows the geographic impact of Liang‐Chuan S. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang‐Chuan S. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang‐Chuan S. Wang more than expected).

Fields of papers citing papers by Liang‐Chuan S. Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liang‐Chuan S. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang‐Chuan S. Wang. The network helps show where Liang‐Chuan S. Wang may publish in the future.

Co-authorship network of co-authors of Liang‐Chuan S. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Liang‐Chuan S. Wang. A scholar is included among the top collaborators of Liang‐Chuan S. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liang‐Chuan S. Wang. Liang‐Chuan S. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intra-tumoral delivery of CXCL11 via a vaccinia virus, but not by modified T cells, enhances the efficacy of adoptive T cell therapy and vaccines 2017 ·OncoImmunology ·Edmund K. Moon,Liang‐Chuan S. Wang,(unknown),Rachel C. Lynn,Albert Lo,Stephen H. Thorne,Steven Μ. Albelda	140
2	CD11b+Ly6G+ cells inhibit tumor growth by suppressing IL-17 production at early stages of tumorigenesis 2015 ·OncoImmunology ·Yuhong Liu,Claire E. O’Leary,Liang‐Chuan S. Wang,Tricia Bhatti,Ning Dai,Veena Kapoor,Peihui Liu,Junjie Mei,Lei Guo,Paula M. Oliver,Steven Μ. Albelda,G. Scott Worthen	32
3	Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cellsbreakdown → 2015 ·Cancer Research ·Albert Lo,Liang‐Chuan S. Wang,John Scholler,James Monslow,Diana Avery,Kheng Newick,Shaun O’Brien,Rebecca A. Evans,David J. Bajor,Cynthia Clendenin,Amy C. Durham,Elizabeth L. Buza,Robert H. Vonderheide,Carl H. June,Steven Μ. Albelda,Ellen Puré	407
4	HDAC5 controls the functions of Foxp3⁺ T‐regulatory and CD8⁺ T cells 2015 ·International Journal of Cancer ·Haiyan Xiao,Jing Jiao,Liqing Wang,Shaun O’Brien,Kheng Newick,Liang‐Chuan S. Wang,(unknown),Yujie Liu,Rongxiang Han,Veena Kapoor,Finn K. Hansen,Thomas Kurz,Wayne W. Hancock,Ulf H. Beier	62
5	Pharmacological inactivation of PI3Kδ in the tumor microenvironment enhances efficacy of other immunotherapeutic agents 2015 ·Journal for ImmunoTherapy of Cancer ·Liang‐Chuan S. Wang,Holly K. Koblish,Michael Hansbury,Yue Zhang,Gengjie Yang,Timothy C. Burn,Paul Waeltz,Mark Rupar,Eddy W. Yue,Brent Douty,Thomas Maduskuie,Nikoo Falahatpisheh,Yunlong Li,Andrew P. Combs,Gregory Hollis,Reid Huber,Peggy Scherle	2
6	Enhanced Effector Responses in Activated CD8+ T Cells Deficient in Diacylglycerol Kinases 2013 ·Cancer Research ·Matthew J. Riese,Liang‐Chuan S. Wang,Edmund K. Moon,Rohan P. Joshi,Anjana Ranganathan,Carl H. June,Gary A. Koretzky,Steven Μ. Albelda	106
7	Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicitybreakdown → 2013 ·Cancer Immunology Research ·Liang‐Chuan S. Wang,Albert Lo,John Scholler,Jing Sun,R. Sonali Majumdar,Veena Kapoor,Michael Antzis,Cody E. Cotner,Laura A. Johnson,Amy C. Durham,Charalambos Solomides,Carl H. June,Ellen Puré,Steven Μ. Albelda	515
8	Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptorbreakdown → 2011 ·Clinical Cancer Research ·Edmund K. Moon,Carmine Carpenito,Jing Sun,Liang‐Chuan S. Wang,Veena Kapoor,Jarrod D. Predina,Daniel J. Powell,James L. Riley,Carl H. June,Steven Μ. Albelda	447
9	Activation of mitogen-activated protein kinases by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) plays an important role in macrophage stimulation 2011 ·Biochemical Pharmacology ·Jing Sun,Liang‐Chuan S. Wang,Zvi G. Fridlender,Veena Kapoor,Guanjun Cheng,Lai‐Ming Ching,Steven Μ. Albelda	14
10	Treating Tumors With a Vaccinia Virus Expressing IFNβ Illustrates the Complex Relationships Between Oncolytic Ability and Immunogenicity 2011 ·Molecular Therapy ·Liang‐Chuan S. Wang,Rachel C. Lynn,Guanjun Cheng,E. A. Alexander,Veena Kapoor,Edmund K. Moon,Jing Sun,Zvi G. Fridlender,Stuart N. Isaacs,Stephen H. Thorne,Steven Μ. Albelda	40
11	Monocyte Chemoattractant Protein–1 Blockade Inhibits Lung Cancer Tumor Growth by Altering Macrophage Phenotype and Activating CD8+ Cells 2010 ·American Journal of Respiratory Cell and Molecular Biology ·Zvi G. Fridlender,Veena Kapoor,George Buchlis,Guanjun Cheng,Jing Sun,Liang‐Chuan S. Wang,Sunil Singhal,Linda A. Snyder,Steven Μ. Albelda	124
12	Labeling of Oxidizable Proteins with a Photoactivatable Analog of the Antitumor Agent DMXAA: Evidence for Redox Signaling in Its Mode of Action 2010 ·Neoplasia ·(unknown),Liang‐Chuan S. Wang,See‐Tarn Woon,(unknown),Kimiora Henare,(unknown),Brian D. Palmer,Stefanie N. Vogel,Claudine Kiéda,(unknown),Lai‐Ming Ching	9
13	Activation of the Nucleotide Oligomerization Domain Signaling Pathway by the Non-bacterially Derived Xanthone Drug 5′6-Dimethylxanthenone-4-acetic Acid (Vadimezan) 2010 ·Journal of Biological Chemistry ·Guanjun Cheng,Jing Sun,Zvi G. Fridlender,Liang‐Chuan S. Wang,Lai‐Ming Ching,Steven Μ. Albelda	17
14	Abstract 24: Labeling of oxidizable proteins with a photoactivatable analog of the antitumor agent DMXAA and evidence for redox signaling in its mode of action 2010 ·Cancer Research ·Lai‐Ming Ching,Liang‐Chuan S. Wang,(unknown),(unknown),Kimiora Henare,Brian D. Palmer	3
15	Neutrophil Influx and Chemokine Production during the Early Phases of the Antitumor Response to the Vascular Disrupting Agent DMXAA (ASA404) 2009 ·Neoplasia ·Liang‐Chuan S. Wang,Lotte Thomsen,R. M. Sutherland,(unknown),(unknown),Chun‐Jen J. Chen,Catherine E. Angel,P. Rod Dunbar,Lai‐Ming Ching	39
16	CCL2 Blockade Augments Cancer Immunotherapy 2009 ·Cancer Research ·Zvi G. Fridlender,George Buchlis,Veena Kapoor,Guanjun Cheng,Jing Sun,Sunil Singhal,(unknown),Liang‐Chuan S. Wang,Daniel F. Heitjan,Linda A. Snyder,Steven Μ. Albelda	151
17	Synthesis and Biological Activity of Azido Analogues of 5,6-Dimethylxanthenone-4-acetic Acid for Use in Photoaffinity Labeling 2007 ·Journal of Medicinal Chemistry ·Brian D. Palmer,Kimiora Henare,See‐Tarn Woon,R. M. Sutherland,(unknown),Liang‐Chuan S. Wang,Claudine Kiéda,Lai‐Ming Ching	19
18	Inhibition of DMXAA-Induced Tumor Necrosis Factor Production in Murine Splenocyte Cultures by NF-κB Inhibitors 2006 ·Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ·Liang‐Chuan S. Wang,See‐Tarn Woon,Bruce C. Baguley,Lai-Ming Ching	12
19	Modulation of thalidomide pharmacokinetics by cyclophosphamide or 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice: the role of tumour necrosis factor 2004 ·Cancer Chemotherapy and Pharmacology ·Francisco Chung,Liang‐Chuan S. Wang,Philip Kestell,Bruce C. Baguley,Lai‐Ming Ching	10
20	Induction of tumour necrosis factor and interferon-γ in cultured murine splenocytes by the antivascular agent DMXAA and its metabolites 2003 ·Biochemical Pharmacology ·Liang‐Chuan S. Wang,(unknown),Bruce C. Baguley,Philip Kestell,R. M. Sutherland,Lai‐Ming Ching	20

About Liang‐Chuan S. Wang

Liang‐Chuan S. Wang is a scholar working on Immunology, Oncology and Virology, having authored 21 papers that have together received 2.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), Immune Cell Function and Interaction (5 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Oncology (1.7k citations), Immunology (949 citations) and Genetics (393 citations). Liang‐Chuan S. Wang has collaborated with scholars based in United States, New Zealand and Germany. Frequent co-authors include Steven Μ. Albelda, Veena Kapoor, Carl H. June, Edmund K. Moon, Albert Lo, Jing Sun, Ellen Puré, Amy C. Durham, John Scholler and Carmine Carpenito. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact